These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21948363)

  • 1. Pathogenic microbes and community service through manipulation of innate immunity.
    Hajishengallis G; Krauss JL; Liang S; McIntosh ML; Lambris JD
    Adv Exp Med Biol; 2012; 946():69-85. PubMed ID: 21948363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen.
    Bostanci N; Belibasakis GN
    FEMS Microbiol Lett; 2012 Aug; 333(1):1-9. PubMed ID: 22530835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researchers: how porphyromonas gingivalis contributes to periodontal disease identified.
    J Am Dent Assoc; 2012 Jan; 143(1):15. PubMed ID: 22303556
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
    Han X; LaRosa KB; Kawai T; Taubman MA
    Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?
    Hajishengallis G
    Microbes Infect; 2009; 11(6-7):637-45. PubMed ID: 19348960
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Bartnicka D; Gonzalez-Gonzalez M; Sykut J; Koziel J; Ciaston I; Adamowicz K; Bras G; Zawrotniak M; Karkowska-Kuleta J; Satala D; Kozik A; Zyla E; Gawron K; Lazarz-Bartyzel K; Chomyszyn-Gajewska M; Rapala-Kozik M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183255
    [No Abstract]   [Full Text] [Related]  

  • 7. Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages.
    Wang M; Shakhatreh MA; James D; Liang S; Nishiyama S; Yoshimura F; Demuth DR; Hajishengallis G
    J Immunol; 2007 Aug; 179(4):2349-58. PubMed ID: 17675496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and dysbiosis in periodontal disease.
    Hajishengallis G; Lambris JD
    Immunobiology; 2012 Nov; 217(11):1111-6. PubMed ID: 22964237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis: major periodontopathic pathogen overview.
    Mysak J; Podzimek S; Sommerova P; Lyuya-Mi Y; Bartova J; Janatova T; Prochazkova J; Duskova J
    J Immunol Res; 2014; 2014():476068. PubMed ID: 24741603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement.
    Hajishengallis G; Liang S; Payne MA; Hashim A; Jotwani R; Eskan MA; McIntosh ML; Alsam A; Kirkwood KL; Lambris JD; Darveau RP; Curtis MA
    Cell Host Microbe; 2011 Nov; 10(5):497-506. PubMed ID: 22036469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice.
    Hajishengallis G; Wang M; Bagby GJ; Nelson S
    J Immunol; 2008 Sep; 181(6):4141-9. PubMed ID: 18768871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo.
    Hajishengallis G; Shakhatreh MA; Wang M; Liang S
    J Immunol; 2007 Aug; 179(4):2359-67. PubMed ID: 17675497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converging findings from linkage between periodontal pathogen with atopic and allergic immune response.
    Nelwan SC; Nugraha RA; Endaryanto A; Meizarini A; Tedjosasongko U; Pradopo S; Utomo H
    Cytokine; 2019 Jan; 113():89-98. PubMed ID: 29937409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
    Rocco CJ; Bakaletz LO; Goodman SD
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Gibson FC; Hong C; Chou HH; Yumoto H; Chen J; Lien E; Wong J; Genco CA
    Circulation; 2004 Jun; 109(22):2801-6. PubMed ID: 15123526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Important Virulence Factors of
    Jia L; Han N; Du J; Guo L; Luo Z; Liu Y
    Front Cell Infect Microbiol; 2019; 9():262. PubMed ID: 31380305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis.
    Xu W; Zhou W; Wang H; Liang S
    Adv Protein Chem Struct Biol; 2020; 120():45-84. PubMed ID: 32085888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis.
    Cutler CW; Kalmar JR; Genco CA
    Trends Microbiol; 1995 Feb; 3(2):45-51. PubMed ID: 7728384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 promoter hypermethylation creates innate immune dysbiosis.
    Benakanakere M; Abdolhosseini M; Hosur K; Finoti LS; Kinane DF
    J Dent Res; 2015 Jan; 94(1):183-91. PubMed ID: 25389002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts.
    Gasiorek A; Dobosz E; Potempa B; Ciaston I; Wilamowski M; Oruba Z; Lamont RJ; Jura J; Potempa J; Koziel J
    mBio; 2021 Jun; 12(3):e0050221. PubMed ID: 34182783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.